StreetInsider.com News Articles

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

In an economy marked by unusual exchange rate volatility, Vetoquinol (Paris:VETO) achieved two important objectives: growth in Essential products and internalization of the manufacturing of the parasiticide range.

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: 2025 Annual Sales

Thu, 29 Jan 2026 11:45:00 -0500

Annual sales: €526 million (up 0.2% at constant exchange rates and down 2.5% on a reported basis)

Annual sales of Essential Products: €334 million (up 4.1% at constant exchange rates and up 2.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol's sales for FY 2025 came to €525.7 million, up 0.2% at constant exchange rates and down 2.5% on a reported basis. Over the financial year, the company recorded historically high

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

9-month sales: €384 million (-1.3% at constant exchange rates and -3.5% on a reported basis)

9-month sales of Essential products: €244 million (64% of sales, +2.7% at constant exchange rates and +1.1% on a reported basis)

LURE, France--(BUSINESS WIRE)-- Regulatory News:

At the end of September 2025, Vetoquinol's (Paris:VETO) sales amounted to €384.2 million, down 3.5% on a reported basis and down 1.3% at constant exchange rates. Over this period, the Group recorded net negative currency impacts of €8.9 million in the Americas and Asia-Pacific/Rest of the World regions and an impact of - €7.7 million from the simplification of

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: Sales at End September 2025

Tue, 28 Oct 2025 12:45:00 -0500

LURE, France--(BUSINESS WIRE)-- Regulatory News:

Vetoquinol: 2025 Half Year Results

Thu, 11 Sep 2025 11:45:00 -0500

Sales: €258m (-1.0% at constant exchange rates)

Essential products sales: €165m (+4.2% at constant exchange rates)

Net income, Group share: €25m (9.7% of sales)

EBITDA: €53m (20.4% of sales)

Cash flow generation: €51m

LURE, France--(BUSINESS WIRE)-- Regulatory News:

The Board of Directors of Vetoquinol SA (Paris:VETO), meeting on September 9, 2025, approved the financial statements for the first half of the 2025 financial year. The limited review report on the financial statements as of June 30, 2025, was issued by the Statutory Auditors.

Vetoquinol's sales amounted to €258 million for the first six months of fiscal year 2025.

Sales of Essentials products amounted to €165

Vetoquinol: 2025 Half Year Results

Thu, 11 Sep 2025 11:45:00 -0500

Sales: €258m (-1.0% at constant exchange rates)

Essential products sales: €165m (+4.2% at constant exchange rates)

Net income, Group share: €25m (9.7% of sales)

EBITDA: €53m (20.4% of sales)

Cash flow generation: €51m

LURE, France--(BUSINESS WIRE)-- Regulatory News:
The Board of Directors of Vetoquinol SA (Paris:VETO), meeting on September 9, 2025, approved the financial statements for the first half of the 2025 financial year. The limited review report on the financial statements as of June 30, 2025, was issued by the Statutory Auditors.
Vetoquinol's sales amounted to €258 million for the first six months of fiscal year 2025.
Sales of Essentials products amounted to €165

Vetoquinol: 2025 Half Year Results

Thu, 11 Sep 2025 11:45:00 -0500

Sales: €258m (-1.0% at constant exchange rates)

Essential products sales: €165m (+4.2% at constant exchange rates)

Net income, Group share: €25m (9.7% of sales)

EBITDA: €53m (20.4% of sales)

Cash flow generation: €51m

LURE, France--(BUSINESS WIRE)-- Regulatory News:
The Board of Directors of Vetoquinol SA (Paris:VETO), meeting on September 9, 2025, approved the financial statements for the first half of the 2025 financial year. The limited review report on the financial statements as of June 30, 2025, was issued by the Statutory Auditors.
Vetoquinol's sales amounted to €258 million for the first six months of fiscal year 2025.
Sales of Essentials products amounted to €165

Vetoquinol: 2025 Half Year Results

Thu, 11 Sep 2025 11:45:00 -0500

Sales: €258m (-1.0% at constant exchange rates)

Essential products sales: €165m (+4.2% at constant exchange rates)

Net income, Group share: €25m (9.7% of sales)

EBITDA: €53m (20.4% of sales)

Cash flow generation: €51m

LURE, France--(BUSINESS WIRE)-- Regulatory News:
The Board of Directors of Vetoquinol SA (Paris:VETO), meeting on September 9, 2025, approved the financial statements for the first half of the 2025 financial year. The limited review report on the financial statements as of June 30, 2025, was issued by the Statutory Auditors.
Vetoquinol's sales amounted to €258 million for the first six months of fiscal year 2025.
Sales of Essentials products amounted to €165

Vetoquinol: 2025 Half Year Results

Thu, 11 Sep 2025 11:45:00 -0500

Sales: €258m (-1.0% at constant exchange rates)

Essential products sales: €165m (+4.2% at constant exchange rates)

Net income, Group share: €25m (9.7% of sales)

EBITDA: €53m (20.4% of sales)

Cash flow generation: €51m

LURE, France--(BUSINESS WIRE)-- Regulatory News:
The Board of Directors of Vetoquinol SA (Paris:VETO), meeting on September 9, 2025, approved the financial statements for the first half of the 2025 financial year. The limited review report on the financial statements as of June 30, 2025, was issued by the Statutory Auditors.
Vetoquinol's sales amounted to €258 million for the first six months of fiscal year 2025.
Sales of Essentials products amounted to €165